Table 2.
The clinical characteristics of study population
| Symptoms, n (%) | |
| Cough | 397 (48.7) |
| Throat ache | 293 (35.9) |
| Fever | 433 (53.1) |
| Anosmia | 73 (8.9) |
| Ageusia | 66 (8.1) |
| Rhinorrhea | 123 (15.1) |
| Headache | 130 (15.9) |
| Weakness | 260 (31.9) |
| Muscle pain | 176 (21.6) |
| Vomiting | 87 (10.7) |
| Diarrhea | 71 (8.7) |
| Rash | 9 (1.1) |
| Dyspnea | 76 (9.3) |
| Diagnosis, n (%) | |
| Asymptomatic (screening test positivity) | 74 (9.1) |
| Just COVID‐19 spesific symptoms | 60 (7.4) |
| Upper respiratory tract infection | 549 (67.3) |
| Pneumonia | 60 (7.4) |
| Acute gastroenteritis | 49 (6) |
| Sinusitis | 9 (1.1) |
| Tuberculosis reactivation | 9 (1.1) |
| Neutropenic fever | 2 (0.2) |
| Sepsis | 3 (0.4) |
| Febrile convulsion | 1 (0.1) |
| Severity of COVID‐19, n (%) | |
| 0 = asymptomatic (screening test positivity) | 76 (9.3) |
| 1 = mild | 667 (81.7) |
| 2 = moderate | 44 (5.4) |
| 3 = severe | 29 (3.6) |
| Prognosis, n (%) | |
| Discharged from the pediatric COVID‐19 policlinic | 684 (83.8) |
| Admission to the hospital | 132 (16.2) |
| Isolation ward | 122 (15) |
| Intensive care unit | 10 (1.2) |
| Length of stay of hospitalized patients, days, median (IQR) | 6 (6) |
| Necessity of oxygen support, n (%) | 54 (6.6) |
| Nasal cannula/mask | 41 (5) |
| BPAP/CPAP | 6 (0.7) |
| Endotracheal intubation | 7 (0.9) |
| Mortality, n (%) | 4 (0.5) |
Note: Data were presented as numbers (%) except for the length of stay in the hospital.
Abbreviations: BPAP, bilevel positive airway pressure; CPAP, continuous positive airway pressure; IQR: interquartile range.